Most Read Articles
4 days ago
Children with high dental anxiety are more likely to develop dental diseases, which, in turn, negatively affect the family’s quality of life, a recent study has found.
3 days ago
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
14 Nov 2019
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
4 days ago
Supplementation with oral nano vitamin D appears to moderate disease activity and severity grade of patients with active ulcerative colitis (UC), suggests a study, adding that this association is more evident in those achieving a target vitamin D level of 40 ng/mL.

Unwrapped hydroxyapatite orbital implant cuts surgical time, avoids complications

23 Sep 2019
The future of eyesight restoration may come from a most unlikely corneal donor – pigs.

A large case series of enucleations has shown a low rate of implant exposure, which indicates that absence of wrapping material around hydroxyapatite orbital implants does not compromise surgical outcomes. It has also reduced surgical time and prevented complications from wrapping materials.

A retrospective review was conducted on consecutive enucleations with primary hydroxyapatite orbital implant insertion performed at the Scottish Ocular Oncology Service between 1990 and 2014. The unwrapped implant was placed in the posterior portion of the socket and recti muscles sutured end-to-end over the implant.

Of the 347 consecutive enucleations, 59.7 percent had an indication of tumour-related pathology and 40.3 percent painful blind eye. Seventy percent received an implant of 22-mm diameter.

Several complications occurred over a mean follow-up of 3.5 years, including postenucleation socket syndrome (11.5 percent), chronic discharge (9.2 percent), chronic pain (4.3 percent), recurrent conjunctival infection (2.3 percent), conjunctival cysts (2 percent), contracted socket (1.4 percent), implant exposure (1.2 percent), haematoma (0.6 percent) and ill-fitting prosthesis (0.6 percent).

Implant exposure (n=4) occurred at an average of 4.5 months after surgery. Management of this complication included temporalis fascia graft (n=1), tarsoconjunctival flap (n=1), implant removal (n=1) and observation (n=1).

Of the patients, 9.8 required further surgery, including lower lid tightening (4.3 percent), ptosis repair (2.3 percent), conjunctival cyst excision (1.2 percent), fornix reconstruction (1.2 percent), graft/flap for exposure (0.6 percent) and implant removal (0.3 percent).

“Posterior implant placement and end-to-end recti suturing contribute to the success of the procedure,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Children with high dental anxiety are more likely to develop dental diseases, which, in turn, negatively affect the family’s quality of life, a recent study has found.
3 days ago
Exposure to corticosteroids in patients with autoimmune hepatitis (AIH) appears to contribute to increased risks of cataract, diabetes and bone fractures, a study has found. Notably, the fracture risk is elevated at low doses, while the risk of adverse events overall is dose-dependent and is reversible.
14 Nov 2019
In patients with atrial fibrillation (AF) and stable coronary artery disease (CAD), rivaroxaban monotherapy is noninferior to combination treatment with an antiplatelet therapy in terms of cutting the risk of cardiovascular events and mortality, according to data from the AFIRE trial.
4 days ago
Supplementation with oral nano vitamin D appears to moderate disease activity and severity grade of patients with active ulcerative colitis (UC), suggests a study, adding that this association is more evident in those achieving a target vitamin D level of 40 ng/mL.